Johanna Nagel - Research output - Lund University

Phone+4646176959
Emailjohanna.nagelmed.luse

8 Article
1 Letter
1 Doctoral Thesis (compilation)

8 results

Filter

2024
Serologic immunogenicity and safety of herpes zoster subunit vaccine in patients with rheumatoid arthritis receiving Janus kinase inhibitors
Källmark, H., Bergström, T., Nagel, J., Gullstrand, B., Einarsson, J. T., Bengtsson, A. A. & Kapetanovic, M. C., 2024 Jul, In: Rheumatology (United Kingdom). 63, 7, p. 2024-2033 10 p.
Research output: Contribution to journal › Article › peer-review

Open Access
2023
Reduced risk of serious pneumococcal infections up to 10 years after a dose of pneumococcal conjugate vaccine in established arthritis.
Nagel, J., Jönsson, G., Nilsson, J.-Å., Manuswin, C., Englund, M., Saxne, T. & C Kapetanovic, M., 2023 Jan 9, In: Vaccine. 41, 2, p. 504-510
Research output: Contribution to journal › Article › peer-review

Open Access
2018
Immunogenicity and safety of pneumococcal vaccination in patients with systemic sclerosis
Hesselstrand, R., Nagel, J., Saxne, T., Geborek, P., Skattum, L. & Kapetanovic, M. C., 2018 Apr 1, In: Rheumatology (United Kingdom). 57, 4, p. 625-630 6 p.
Research output: Contribution to journal › Article › peer-review
2017
Immune response to pneumococcal conjugate vaccine in patients with systemic vasculitis receiving standard of care therapy
Nived, P., Nagel, J., Saxne, T., Geborek, P., Jönsson, G., Skattum, L. & Kapetanovic, M. C., 2017 Jun 22, In: Vaccine. 35, 29, p. 3639-3646
Research output: Contribution to journal › Article › peer-review
Methotrexate reduces vaccine-specific immunoglobulin levels but not numbers of circulating antibody-producing B cells in rheumatoid arthritis after vaccination with a conjugate pneumococcal vaccine
Kapetanovic, M. C., Nagel, J., Nordström, I., Saxne, T., Geborek, P. & Rudin, A., 2017, In: Vaccine. 35, 6, p. 903-908
Research output: Contribution to journal › Article › peer-review

Open Access
File
244 Downloads (Pure)
Treatment with belimumab in systemic lupus erythematosus does not impair antibody response to 13-valent pneumococcal conjugate vaccine.
Nagel, J., Geborek, P., Bengtsson, A., Jacobsen, S., Joergensen C, S., Nilsson, J.-Å., Skattum, L. M., Jönsen, A. & C Kapetanovic, M., 2017, In: Lupus. 26, 10, p. 1072-1081
Research output: Contribution to journal › Article › peer-review
2015
The association between antibody levels before and after 7-valent pneumococcal conjugate vaccine immunization and subsequent pneumococcal infection in chronic arthritis patients.
Nagel, J., Geborek, P., Saxne, T., Jönsson, G., Englund, M., Petersson, I., Nilsson, J.-Å., Truedsson, L. & C Kapetanovic, M., 2015, In: Arthritis Research and Therapy. 17, 1, 124.
Research output: Contribution to journal › Article › peer-review

File
230 Downloads (Pure)
The risk of pneumococcal infections after immunization with pneumococcal conjugate vaccine compared to non-vaccinated inflammatory arthritis patients.
Nagel, J., Geborek, P., Saxne, T., Jönsson, G., Englund, M., Petersson, I., Nilsson, J.-Å. & C Kapetanovic, M., 2015, In: Scandinavian Journal of Rheumatology. 44, 4, p. 271-279
Research output: Contribution to journal › Article › peer-review